May 20, 2022 | News, Uncategorized
May 20, 2022 – Eiger BioPharmaceuticals Inc. and The Progeria Research Foundation (PRF), announced today that Eiger has received a positive opinion from the CHMP recommending approval for Zokinvy, a breakthrough treatment for Hutchinson Gilford progeria...
May 4, 2022 | Homepage News, News, Uncategorized
In May 2022, The Progeria Research Foundation in partnership with Brigham and Women’s Hospital, and Boston Children’s Hospital convened a specialized meeting of high-level cardiologists and researchers to discuss the urgency of cardiac stenosis in children with...
